Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Finerenone bulk supplier for pharma manufacturers

Finerenone 10mg, 20mg Suppliers & Bulk Manufacturers

Available Forms: Tablets

Available Strengths: 10mg, 20mg

Reference Brands: Kerendia(USA/EU)

Category: Nephrology

Finerenone is a non‑steroidal, selective mineralocorticoid receptor antagonist. It blocks mineralocorticoid receptor overactivation, which can cause inflammation and scarring in the kidneys. It helps reduce the risk of kidney‑function decline, progression to kidney failure, and cardiovascular events in adults with chronic kidney disease associated with type 2 diabetes.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

📘 Sourcing Guide

Finerenone — third party manufacturing & bulk supply

Finerenone 10mg, 20mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

What to include when you enquire

  • Destination market — determines which manufacturers hold the right site-level approvals
  • First order quantity and estimated annual volume
  • Whether you need a registration dossier or the product is already registered
  • Packaging, labelling and language requirements
  • Incoterms and required shelf life

Manufacturers of Finerenone listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.

Request a quote for Finerenone →
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing

Frequently Asked Questions

Finerenone is used to reduce the risk of cardiovascular events and slow the progression of chronic kidney disease (CKD) in adults with type 2 diabetes. It works as a non-steroidal mineralocorticoid receptor antagonist, helping manage inflammation and fibrosis in the kidneys and heart.

Finerenone is made from the active pharmaceutical ingredient finerenone, a synthetic non-steroidal molecule that selectively blocks mineralocorticoid receptors.

The trade name is Kerendia.

Kerendia is manufactured by Bayer AG.

The generic name is finerenone.

The primary brand name is Kerendia.

It is manufactured in approved facilities in Europe and the USA, depending on the regulatory approvals for each region.

Related Products

Atrasentan Hydrochloride

Strength:
0.75 mg, 1.25 mg, 10 mg

Form: Tablets

Reference Brands: Xinlay (USA/EU), Vanrafia (USA/LATAM)

View Details
Tiopronin

Strength:
100 mg, 200 mg , 300 mg

Form: Tablets, Capsules

Reference Brands: Thiola (USA), Mercaptamine (EU)

View Details
Nedosiran

Strength:
80 mg, 160 mg

Form: Injection

Reference Brands: Ryplazim (USA)

View Details
Probenecid

Strength:
500 mg

Form: Tablets

Reference Brands: Benemid (USA)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.